华绿生物
(300970)
| 流通市值：11.57亿 | | | 总市值：14.94亿 |
| 流通股本：9306.09万 | | | 总股本：1.20亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 735,466,949.07 | 462,529,323.08 | 256,905,255.97 | 996,221,375.81 |
| 营业收入 | 735,466,949.07 | 462,529,323.08 | 256,905,255.97 | 996,221,375.81 |
| 二、营业总成本 | 772,482,385.4 | 508,635,192.56 | 257,780,429.22 | 959,058,269.35 |
| 营业成本 | 698,625,329.08 | 460,811,781.49 | 236,078,230.42 | 861,515,565.81 |
| 税金及附加 | 523,982.5 | 350,838.08 | 140,975.8 | 553,097.67 |
| 销售费用 | 8,024,933.44 | 5,313,301.36 | 2,981,054.76 | 9,496,818.47 |
| 管理费用 | 51,480,419 | 35,168,069.34 | 17,671,183.25 | 70,827,874.62 |
| 研发费用 | 11,772,434.56 | 6,517,335.67 | 1,857,734.25 | 16,528,200.57 |
| 财务费用 | 2,055,286.82 | 473,866.62 | -948,749.26 | 136,712.21 |
| 其中:利息费用 | 5,324,550.55 | 3,418,792.75 | - | 8,746,869.77 |
| 其中:利息收入 | -3,300,864.44 | 2,970,184.86 | - | 8,636,168.21 |
| 加:公允价值变动收益 | - | - | - | -173,780.82 |
| 加:投资收益 | 86,571.69 | 86,571.69 | - | 540,243.73 |
| 资产处置收益 | -178,857.96 | -121,493.42 | -16,844.24 | -10,893,647.2 |
| 资产减值损失(新) | -4,196,358.12 | -4,193,982.54 | 32,648.7 | -8,336,377.16 |
| 信用减值损失(新) | -848,691.74 | -844,730.42 | -4,773.07 | -2,356,056.55 |
| 其他收益 | 8,290,090.16 | 5,875,645.68 | 3,096,846.97 | 11,221,433.97 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | -33,862,682.3 | -45,303,858.49 | 2,232,705.11 | 27,164,922.43 |
| 加:营业外收入 | 430,269.9 | 326,075.54 | 254,141.36 | 211,404.96 |
| 减:营业外支出 | 487,047.37 | 329,835.14 | 59,579.45 | 1,007,905.81 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | -33,919,459.77 | -45,307,618.09 | 2,427,267.02 | 26,368,421.58 |
| 减:所得税费用 | 115,369.48 | 77.88 | 61.06 | 1.78 |
| 六、净利润 | -34,034,829.25 | -45,307,695.97 | 2,427,205.96 | 26,368,419.8 |
| 持续经营净利润 | - | -45,307,695.97 | - | 26,368,419.8 |
| 归属于母公司股东的净利润 | -35,089,857.04 | -44,824,475.05 | 1,739,546.28 | 30,348,940.26 |
| 少数股东损益 | 1,055,027.79 | -483,220.92 | 687,659.68 | -3,980,520.46 |
| (一)基本每股收益 | -0.3 | -0.38 | 0.02 | 0.26 |
| (二)稀释每股收益 | -0.3 | -0.38 | 0.02 | 0.26 |
| 九、综合收益总额 | -34,034,829.25 | -45,307,695.97 | 2,427,205.96 | 26,368,419.8 |
| 归属于母公司股东的综合收益总额 | -35,089,857.04 | -44,824,475.05 | 1,739,546.28 | 30,348,940.26 |
| 归属于少数股东的综合收益总额 | 1,055,027.79 | -483,220.92 | 687,659.68 | -3,980,520.46 |
| 公告日期 | 2024-10-29 | 2024-08-28 | 2024-04-23 | 2024-04-23 |
| 审计意见(境内) | | | | 标准无保留意见 |